EXPERTISE
Life Sciences & Healthcare

Category Management Agreements: Belgian Competition Authority issues landmark decision in cartel case involving anti-competitive arrangements for the placement of OTC medicines in pharmacies

April 2025 – On 24 April 2025, the Belgian Competition Authority (“BCA”) announced that it had imposed fines totalling EUR 11.2 million on pharmaceutical companies Johnson & Johnson, Boehringer Ingelheim, and Haleon. The sanctions were issued...

Kinstellar advises Blue Sea Capital on the sale of MediGroup Serbia to Mehiläinen Group

April 2025 – Kinstellar is pleased to announce that it has advised Blue Sea Capital on the sale of MediGroup, Serbia’s largest private healthcare provider, to Mehiläinen Group, Finland’s largest private healthcare provider. The transaction forms...

Kinstellar advises Macopharma Group – GMPi on its acquisition of Lmb Technologie

April 2025 – We are delighted to announce that the Kinstellar Belgrade team, in collaboration with international advisor Forvis Mazars Germany, has successfully advised Macopharma Group – GMPi, a global leader in the healthcare industry, on its acquisition...

Hartwig Kienast, a leading Austrian M&A lawyer, joins Kinstellar as Partner in Vienna

April 2025 – Kinstellar is delighted to announce that Hartwig Kienast, a highly regarded M&A lawyer, has joined our newly launched Vienna office as a Partner. His arrival further strengthens our M&A and private equity capabilities in Austria...

Kinstellar advises private investment group EMMA Capital on the strategic acquisition of Diamedix in Romania, Moldova, Bulgaria, and Ukraine

March 2025 – Kinstellar is pleased to announce that it has advised EMMA Capital Group, a private investment group, on its acquisition of Diamedix, one of Romania’s largest independent medical equipment distributors. The deal, closed through EMMA Capital’s...

Cybersecurity: Romania transposes the NIS2 Directive. What’s next?

February 2025 – Directive (EU) 2022/2555 (NIS2) aims to further strengthen the cyber resilience of the EU by requiring entities in various sectors to dial up their cybersecurity efforts. NIS2 replaces the former NIS1 Directive (EU) 2016/1148, expands...

Kinstellar advises on Central Asia’s largest healthcare PPP project

November 2024 – Kinstellar is proud to announce its involvement in the development of Central Asia's largest public-private partnership (PPP) medical facility in Kokshetau, Kazakhstan. With financing led by the European Bank for Reconstruction and Development...

Kinstellar advises Ardian on the Romanian side of the transaction for the acquisition of a majority interest in Vista Vision

November 2024 – Kinstellar is proud to have advised Ardian, one of the world’s leading private equity investment companies, on the Romanian side of the transaction for the acquisition of a majority interest in Vista Vision, a leading provider of healthcare...

Ukraine advances toward introducing medical cannabis circulation

October 2024 – During September and early October, the Ukrainian government adopted secondary legislation to further the implementation of the so-called Cannabis Law.

Hugh Owen, a top M&A lawyer in Central and South Eastern Europe, joins Kinstellar as Partner

October 2024 – Kinstellar is very pleased to announce that Hugh Owen joins the Firm as a Partner, effective 1 October 2024.